Journal of Pharmacy Practice and Education

About Journal of Pharmacy Practice and Education

Journal of Pharmacy Practice and Education is an Open Access, peer–reviewed, academic journal which has a wide range of fields which creates a platform for the authors to publish a relatively reliable source of information on recent discoveries, review articles, original articles etc. and provides free online access to the researchers worldwide.

Journal of pharmacy practices and education also involves the latest interest in the field of pharmacy and publishes articles in the field of good pharmacy practices, dispensing pharmacy, community pharmacy, clinical pharmacy, pharmacovigilence, quality control, quality assurance, self-medication, pharmaceutical care, cronic patient need ,hospital pharmacy, pharmaceutical services, pharmacoeconomic analysis, patient counselling, health prevention, medication records , prescription handling, pharmacy informatics, veterinary pharmacy, internet pharmacy, compounding pharmacy, pharmaceutical sciences, consultant pharmacy, ambulatory care pharmacy, pharmacy techniques, over the counter drugs, overmedication , public health, medication errors, patient compliance, compounding, health care practitioner, pharmacology, pharmacognosy , drug interactions, pharmacokinetics, pharmacodynamics, good manufacturing practices, good clinical practices. It encourages research scholars, academicians, professionals and students engaged in their particular fields.

 Author may submit their manuscripts through the journal's online submission as an e-mail attachment at [email protected]


Pharmacovigilance (PV or PhV), is also known as drug safety, is the pharmacological science which relates to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. The roots for the word are "pharmacovigilance" are: pharmakon (Greek for drug) and vigilare (Latin for to keep watch). As such, pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy.

Clinical pharmacy

Clinical pharmacy is the pharmacy practice and is the branch of pharmacy in which pharmacists provide patient care that optimizes the use of medication and promotes health, wellness, and disease prevention. Clinical pharmacists care for patients in all health care settings but the clinical pharmacy movement initially began inside hospitals and clinics. Clinical pharmacists often work in collaboration with physicians, nurse practitioners, and other healthcare professionals.

Practices in Hospital Pharmacy

Practices in Hospital pharmacies are pharmacies usually found within the premises of a hospital. Hospital pharmacies usually stock a larger range of medications, including more specialized and investigational medications (medicines that are being studied, but have not yet been approved), than would be feasible in the community setting. Hospital pharmacies typically provide medications for the hospitalized patients only, and are not retail establishments and therefore typically do not provide prescription service to the public

Drug Pharmacology

Drug Pharmacology is the branch of biology concerned with the study of drug action, where a drug can be broadly defined as any man-made, natural, or endogenous (from within body) molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism (sometimes the word pharmacon is used as a term to encompass these endogenous and exogenous bioactive species). More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function.

Pharmaceutical analysis

Pharmaceutical analysis is a branch of pharmaceutical chemistry that involves a series of process for identification, determination, quantification and purification of a substance, separation of the components of a solution or mixture, or determination of structure of chemical compounds.

Plant Pharmacognosy

Plant Pharmacognosy is the study of medicinal drugs derived from plants or other natural sources. The American Society of Pharmacognosy defines pharmacognosy as "the study of the physical, chemical, biochemical and biological properties of drugs, drug substances or potential drugs or drug substances of natural origin as well as the search for new drugs from natural sources". It is also defined as the study of crude drugs.

Drug Pharmacokinetics

Drug Pharmacokinetics is made up from Ancient Greek pharmakon "drug" and kinetikos "moving, putting in motion"; see chemical kinetics), sometimes abbreviated as PK, is a branch of pharmacology dedicated to determining the fate of substances administered to a living organism. The substances of interest include any chemical xenobiotic such as: pharmaceutical drugs, pesticides, food additives, cosmetic ingredients, etc. It attempts to analyze chemical metabolism and to discover the fate of a chemical from the moment that it is administered up to the point at which it is completely eliminated from the body.

Drug Pharmacodynamics

Drug Pharmacodynamics is the study of the biochemical and physiologic effects of drugs (especially the pharmaceutical drugs). The effects can include those manifested within animals(including humans), microorganisms, or combinations of organisms. Pharmacodynamics is the study of how a drug affects an organism. Pharmacodynamics is sometimes abbreviated as PD and pharmacokinetics as PK, especially in combined reference.

Good manufacturing practices (GMP)

Good manufacturing practices (GMP) are the practices which are required in order to conform to the guidelines recommended by agencies that control authorization and licensing for manufacture and sale of food, drug products, and active pharmaceutical products. These guidelines provide minimum requirements that a pharmaceutical or a food product manufacturer must meet to assure that the products are of high quality and do not pose any risk to the consumer or public.

General Pharmaceutics

General Pharmaceutics is the discipline of pharmacy that deals with the process of turning a new chemical entity (NCE) or old drugs into a medication to be used safely and effectively by patients. It is also called the science of dosage form design. There are many chemicals with pharmacological properties, but need special measures to help them achieve therapeutically relevant amounts at their sites of action. Pharmaceutics helps relate the formulation of drugs to their delivery and disposition in the body. Pharmaceutics deals with the formulation of a pure drug substance into a dosage form.

Pharmaceutical Adverse Drug Reaction

An adverse drug reaction (ADR) is an injury caused by taking a medication. ADRs may occur following a single dose or prolonged administration of a drug or result from the combination of two or more drugs. The study of ADRs is the concern of the field known as pharmacovigilance. An adverse drug event (ADE) refers to any injury occurring at the time a drug is used, whether or not it is identified as a cause of the injury. An ADR is a special type of ADE in which a causative relationship can be shown.

Pharmaceutical Toxicology

Pharmaceutical Toxicology is a discipline, overlapping with biology, chemistry, pharmacology, medicine, and nursing, that involves the study of the adverse effects of chemical substances on living organisms and the practice of diagnosing and treating exposures to toxins and toxicants. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Factors that influence chemical toxicity include the dosage (and whether it is acute or chronic), route of exposure, species, age, sex, and environment. The Toxicologists are experts on poisons and poisoning.

Pharmaceutical Clinical Trials

Pharamaceutical Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.

Recent Articles